Hubert Low

Dr. Hubert Low is a Clinical Associate Professor at the Central Clinical School within the University of Sydney's Faculty of Medicine and Health. His research focuses on head and neck oncology, facial nerve reconstruction, and surgical outcomes in cancer patients. He collaborates extensively with multidisciplinary teams, including surgeons, oncologists, and engineers, to develop novel treatments for facial paralysis and reconstructive challenges. His work spans clinical trials, surgical innovation, and translational research in cancer staging and immunology.

Education details are not explicitly provided, but his academic role suggests advanced training in medicine and surgical specialties. Research interests include improving surgical techniques for head and neck cancers, understanding metastatic patterns, and enhancing quality of life through reconstructive interventions. His studies often address nodal staging systems, perineural invasion, and the impact of surgical margins on outcomes.

Dr. Low has authored over 100 peer-reviewed articles since 2017, focusing on topics like salivary gland cancer classification, facial nerve paralysis interventions, and genomic analyses of squamous cell carcinoma. He leads projects involving implantable prosthetics for dynamic eye closure and has pioneered the use of ovine models for surgical testing. His work on the Milan System modifications and virtual surgical planning reflects innovation in clinical practice.

He advises at least one current PhD student, Aki, focusing on immune predictors in cutaneous SCC. Collaborations include institutions like the ANZ Journal of Surgery and multidisciplinary teams at Sydney's tertiary cancer centers. His clinical practice integrates cutting-edge surgical methods with patient-centered care, addressing complex cases such as osteoradionecrosis and free flap reconstructions.

Labs and teams: Active member of Sydney's Head and Neck Cancer Research Group and the Sydney Facial Nerve Clinic. Engaged in projects with biomedical engineers to develop dynamic facial reanimation devices.